Suppr超能文献

中性粒细胞减少患者停止抗生素治疗。

Stopping antibiotic therapy in neutropenic patients.

作者信息

DiNubile M J

机构信息

Department of Medicine, Cooper Hospital/University Medical Center, Camden, New Jersey.

出版信息

Ann Intern Med. 1988 Feb;108(2):289-92. doi: 10.7326/0003-4819-108-2-289.

Abstract

Infection is the major cause of death in neutropenic patients. Because of the lack of acute inflammatory cells, the usual signs of infection are often absent in these patients. Therefore, unexplained fever in a neutropenic patient requires prompt initiation of antibiotic therapy. Many physicians advocate continuing antibiotic therapy until neutropenia resolves. However, prolonged treatment with broad-spectrum antibiotics increases the risks of drug toxicity and superinfection with resistant bacteria and fungi. Based on a critical review of the literature and a large personal clinical experience, I offer tentative guidelines for withdrawing antibiotic therapy in persistently neutropenic patients. When antibiotic therapy is discontinued, frequent and careful monitoring of these patients and a low threshold for reinstituting antibiotic therapy are essential.

摘要

感染是中性粒细胞减少患者死亡的主要原因。由于缺乏急性炎症细胞,这些患者通常没有感染的常见体征。因此,中性粒细胞减少患者出现不明原因发热需要立即开始抗生素治疗。许多医生主张持续使用抗生素治疗,直到中性粒细胞减少症缓解。然而,长期使用广谱抗生素会增加药物毒性以及耐药细菌和真菌感染的风险。基于对文献的批判性回顾和丰富的个人临床经验,我为持续中性粒细胞减少患者停用抗生素治疗提供初步指导原则。当停用抗生素治疗时,对这些患者进行频繁且仔细的监测以及重新使用抗生素治疗的低阈值至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验